Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVolex Regulatory News (VLX)

Share Price Information for Volex (VLX)

Share Price is delayed by 15 minutes
Get Live Data
637.00    -42.00 (-6.19%)
Bid:
637.00
Ask:
638.00
Spread: 1.00 (0.157%)
Market Cap: £1.17b
VLX Live PriceLast checked at - London Stock Exchange

Intraday Volex Share Chart

AGM Statement

19 Aug 2022 07:00

RNS Number : 5395W
Volex PLC
19 August 2022
 

Volex plc

("Volex" or the "Company")

AGM Statement

Strong start to FY2023 and continued progress across the business

Volex plc (AIM: VLX), the global manufacturer supplying power products and integrated manufacturing services, today issues a trading update for the three months ended 30 June 2022 ahead of the Company's Annual General Meeting, being held today at 4:00pm BST.

 

Continued momentum

Volex's performance in the first quarter has been strong, in line with management's expectations and the new, five-year growth plan.

 

Revenues grew organically by 4.9% reflecting positive customer demand and our ability to deliver against the backdrop of a challenging supply chain environment.

 

As outlined at the Company's full year results in June 2022, we have continued to maintain high levels of utilisation across each region, with higher inventory levels than the previous year in order to support the timely delivery of complex products to customers.

 

Integration of the acquisitions made during FY2022 is progressing well and Volex continues to develop a strong acquisition pipeline.

 

Supportive end market conditions

The Company's diverse end markets continue to support Volex's long-term strategic plans and affords the Group a high degree of resilience:

 

· Electric Vehicles: Continued revenue growth resulting from the investment we have made to enhance our capabilities and enable us to support a range of products for our EV customers.

 

· Consumer Electricals: Revenues continue to grow, reflecting increasing market share through selling activity, as well as the delivery of new customer projects.

 

· Medical: Demand from Medical customers remains robust and revenues are ahead of the previous year, despite challenges due to the limited availability of components.

 

· Complex Industrial Technology: Demand in our core business remains strong, next-generation high speed cable volumes are expected to increase in future periods as customers accelerate their technology replacement programmes.

 

Outlook

Management continues to focus on diversification, vertical integration and realising cross-selling opportunities across the business in order to deliver sustainable revenue growth.

 

Overall, whilst still early in the year, the encouraging trends in the first quarter mean the Board expects to deliver full year underlying operating profit in line with current market expectations1.

 

1 Latest company compiled view of market expectations shows an underlying operating profit consensus of $62.8 million with a range of $62.3 million to $64.0 million.

 

 

For further information please contact:

Volex plc

Nat Rothschild, Executive Chairman

Jon Boaden, Chief Financial Officer

+44 (0)7971 156 431

investor.relations@volex.com

 

Singer Capital Markets - Nominated Adviser & Joint Broker

Shaun Dobson

George Tzimas

+44 (0)20 7496 3000

 

HSBC Bank plc - Joint Broker

Simon Alexander

Joe Weaving

+44 (0)20 7991 8888

 

Powerscourt - Media Enquiries

James White

Nicholas Johnson 

Maxim Hibbs

+44 (0)20 7250 1446

 

About Volex

 

Volex plc (AIM: VLX) is a global leader in integrated manufacturing for performance-critical applications and a supplier of power products. We serve a diverse range of markets and customers, with particular expertise in cable assemblies, higher-level assemblies, data centre power and connectivity, electric vehicles, and consumer electricals. We are headquartered in the UK and operate from 19 manufacturing locations with a global workforce of over 7,800 employees across 22 countries. Our products are sold through our own locally based sales teams and through authorised distributor partners to Original Equipment Manufacturers ('OEMs') and Electronic Manufacturing Services ('EMS') companies worldwide. All of the products and services that we offer are integral to the increasingly complex digital world in which we live, providing power and connectivity from the most common household items to the most complex medical equipment. For more information, please visit www.volex.com 

 

-ENDS-

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMSFLFUAEESEIA
Date   Source Headline
26th May 20263:00 pmRNSNotice of Results
15th May 20267:45 amRNSHolding(s) in Company
11th May 20267:00 amRNSHolding(s) in Company
30th Apr 20263:07 pmRNSHolding(s) in Company
22nd Apr 20267:00 amRNSCapital Markets Event
7th Apr 20267:00 amRNSLaunch of £40 million Share Buyback Programme
7th Apr 20267:00 amRNSUpdate on Move to the Main Market
26th Mar 20265:30 pmRNSHolding(s) in Company
25th Mar 20267:00 amRNSTrading update and Notice of Capital Markets Event
20th Mar 20262:00 pmRNSDirector/PDMR Shareholding
10th Feb 20267:45 amRNSHolding(s) in Company
2nd Feb 20264:45 pmRNSDirector/PDMR Shareholding
30th Jan 20264:30 pmRNSDirector/PDMR Shareholding
21st Jan 20267:00 amRNSTrading Update
12th Jan 20265:30 pmRNSDirector/PDMR Shareholding
8th Jan 20262:00 pmRNSDirector/PDMR Shareholding
5th Jan 20263:00 pmRNSIssue of Equity and Total Voting Rights
15th Dec 20257:00 amRNSDirector/PDMR Shareholding
11th Dec 20255:55 pmRNSDirector/PDMR Shareholding
4th Dec 202511:30 amRNSScrip Reference Price
12th Nov 20257:00 amRNSAppointment of Non-Executive Chair and CEO
12th Nov 20257:00 amRNSHalf-year Report
20th Oct 20257:00 amRNSNotice of Results
16th Oct 20257:00 amRNSHalf Year Trading Update
29th Sep 20251:25 pmRNSHolding(s) in Company
18th Sep 20257:00 amRNSHolding(s) in Company
15th Sep 202511:30 amRNSDirector/PDMR Shareholding
15th Sep 202510:15 amRNSHolding(s) in Company
5th Sep 20259:00 amRNSDirector/PDMR Shareholding
1st Sep 20251:00 pmRNSIssue of Equity and Total Voting Rights
7th Aug 20254:35 pmRNSResult of AGM
7th Aug 202512:30 pmRNSScrip Reference Price
7th Aug 20257:00 amRNSAGM Statement
4th Aug 20252:00 pmRNSHolding(s) in Company
7th Jul 20254:35 pmRNSPDMR / PCA Shareholding
4th Jul 202511:00 amRNSNotice of AGM and Publication of Annual Report
26th Jun 20257:00 amRNSPreliminary Group Results FY2025
2nd Jun 20257:00 amRNSNotice of Results and Investor Presentation
16th Apr 20252:00 pmRNSDirector/PDMR Shareholding
16th Apr 20251:00 pmRNSDirector/PDMR Shareholding
10th Apr 20256:00 pmRNSDirector/PDMR Shareholding
7th Apr 20257:00 amRNSFull Year Trading Update
19th Mar 20253:30 pmRNSDirector/PDMR Shareholding
13th Mar 20255:45 pmRNSHolding(s) in Company
27th Jan 20257:00 amRNSChange of Adviser
27th Jan 20257:00 amRNSTrading Update
16th Jan 20251:15 pmRNSDirector/PDMR Shareholding
16th Jan 20251:15 pmRNSDirector/PDMR Shareholding
3rd Jan 20257:00 amRNSDeferred Consideration for Acquisition
19th Dec 20247:00 amRNSForm 8.3 - Volex PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.